AML

Article

Risk classification at diagnosis predicts post-HCT outcomes in AML

• Read More

Article

No worsening of fatigue or health-related quality of life with oral azacitidine maintenance in AML patients in remission

• Read More

Article

COVID-19 mortality higher in patients with active AML vs. those in remission

• Read More

Article

Allo-HSCT in CR1 beneficial for elderly AML patients with unfavorable or intermediate-risk cytogenetics

• Read More

Article

Varied outcomes in AML patients with NPM-mutant MRD+ at end of IC

• Read More

Article

LDAC+venetoclax shows promise as frontline therapy in treatment-naive AML patients unfit for IC

• Read More

Article

R/R AML: Mito-FLAG improves response, but allo-HSCT remains essential for prolonged survival

• Read More

Article

Intensification of induction II does not improve outcomes in pediatric high-risk AML

• Read More

Article

Addition of quizartinib to LDAC improves outcomes in older patients with FLT3-ITD-mutated AML

• Read More

Conference Coverage

HMAs benefit children with relapsed/refractory AML

Author:

Neil Osterweil

Azacitidine and decitabine alone or in combination may help children and young adults reach stem cell transplant...

• Read More

Conference Coverage

Reduced-intensity transplant benefits older patients with AML

Author:

Nancy A. Melville

This improvement in survival is seen regardless of key factors such as genotype and the status of minimal...

• Read More